Quest Diagnostics
DGX
Quest Diagnostics (DGX) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $3.12
- EPS estimate
- $2.82
- EPS surprise
- +10.52%
- Revenue surprise
- +2.36%
- Revenue
- $3.0B
- Revenue estimate
- $3.0B
- Reported
- Jul 23, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 23, 2026 | $2.82 | $3.12 | +10.52% | $3.0B | SEC |
| Q1 2026 | Apr 21, 2026 | $2.37 | $2.50 | +5.67% | $2.9B | SEC |
| Q4 2025 | Feb 10, 2026 | $2.37 | $2.42 | +2.10% | $2.8B | SEC |
| Q3 2025 | Oct 21, 2025 | $2.50 | $2.60 | +3.88% | $2.8B | SEC |
| Q2 2025 | Jul 22, 2025 | $2.57 | $2.62 | +1.93% | $2.8B | SEC |
| Q1 2025 | Apr 22, 2025 | $2.15 | $2.21 | +2.71% | $2.7B | SEC |
| Q4 2024 | Jan 30, 2025 | $2.19 | $2.23 | +2.02% | $2.6B | SEC |
| Q3 2024 | Oct 22, 2024 | $2.26 | $2.30 | +1.60% | $2.5B | SEC |
| Q2 2024 | Jul 23, 2024 | $2.33 | $2.35 | +0.65% | $2.4B | SEC |
| Q1 2024 | Apr 23, 2024 | $1.86 | $2.04 | +9.94% | $2.4B | SEC |
| Q4 2023 | Feb 1, 2024 | $2.11 | $2.15 | +1.72% | $2.3B | SEC |
| Q3 2023 | Oct 24, 2023 | $2.19 | $2.22 | +1.45% | $2.3B | SEC |
| Q2 2023 | Jul 26, 2023 | $2.27 | $2.30 | +1.46% | $2.3B | SEC |
| Q1 2023 | Apr 27, 2023 | $1.97 | $2.04 | +3.31% | $2.3B | SEC |
| Q4 2022 | Feb 2, 2023 | $1.91 | $1.98 | +3.61% | $2.3B | SEC |
| Q3 2022 | Oct 20, 2022 | $2.19 | $2.36 | +7.59% | $2.5B | SEC |
| Q2 2022 | Jul 21, 2022 | $2.29 | $2.36 | +2.99% | $2.5B | SEC |
| Q1 2022 | Apr 21, 2022 | $2.99 | $3.22 | +7.62% | $2.6B | SEC |
| Q4 2021 | Feb 3, 2022 | $3.22 | $3.33 | +3.35% | $2.7B | SEC |
| Q3 2021 | Oct 21, 2021 | $2.88 | $3.96 | +37.72% | $2.8B | SEC |
Quarterly revenue
Frequently asked questions
When did Quest Diagnostics (DGX) last report earnings?
Quest Diagnostics last reported on Jul 23, 2026, covering fiscal Q2 2026.
Did DGX beat earnings estimates?
Yes. Quest Diagnostics reported EPS of $3.12 for Q2 2026 against a $2.82 estimate — a 10.52% beat.
How much revenue did DGX report last quarter?
Quest Diagnostics reported $3.0B in revenue for Q2 2026, against a consensus estimate of $3.0B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.